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Interactions between the microbiota and distal gut
are fundamental determinants of human health.
Such interactions are concentrated at the colonic
mucosa and provide energy for the host epithelium
through the production of the short-chain fatty acid
butyrate. We sought to determine the role of epithe-
lial butyrate metabolism in establishing the austere
oxygenation profile of the distal gut. Bacteria-
derived butyrate affects epithelial O2 consumption
and results in stabilization of hypoxia-inducible fac-
tor (HIF), a transcription factor coordinating barrier
protection. Antibiotic-mediated depletion of the
microbiota reduces colonic butyrate and HIF expres-
sion, both of which are restored by butyrate supple-
mentation. Additionally, germ-free mice exhibit
diminished retention of O2-sensitive dyes and
decreased stabilized HIF. Furthermore, the influ-
ences of butyrate are lost in cells lacking HIF, thus
linking butyrate metabolism to stabilized HIF and
barrier function. This work highlights a mechanism
where host-microbe interactions augment barrier
function in the distal gut.
INTRODUCTION
The mammalian GI tract harbors trillions of bacteria. A finely
balanced mutualism exists within the intestinal mucosa, where
microbes, essential for host health, can also initiate and
perpetuate mucosal disease (Lozupone et al., 2012). Nutrient
provision by microbes is one benefit enjoyed by the host. In
addition to aiding in digestion, microbes produce a number of662 Cell Host & Microbe 17, 662–671, May 13, 2015 ª2015 Elsevier Ivitamins and benefit the host through the local synthesis
of short-chain fatty acids (SCFAs), including butyrate, propio-
nate, and acetate. SCFAs can reach luminal concentrations
of 130 mM in the proximal colon, and butyrate in particular
serves as the preferred metabolic substrate for intestinal
epithelial cells (Hamer et al., 2008). A decrease of butyrate-
producing microbial species has been inversely associated
with colonic disease, including inflammatory bowel disease,
supporting the view that butyrate is a critical determinant of
disease resistance (Machiels et al., 2013; Eeckhaut et al.,
2013; Sokol et al., 2009).
The low-O2 conditions that enable SCFA production also
place unusual metabolic demands on the colonic epithelium. A
steep O2 gradient traverses the surface of the colonic mucosa
between the O2-rich lamina propria and the gut lumen, which
is dominated by anaerobic organisms (Albenberg et al., 2014).
Situated at this interface, the colonic epithelium functions at a
pO2 well below that of other tissues (He et al., 1999). Not surpris-
ingly, the colonic epithelium is uniquely adapted to this austere
environment, and cellular programming by this ‘‘physiologic
hypoxia’’ has been shown to tonally regulate intestinal barrier
function (Colgan and Taylor, 2010). HIF is the major cellular
mechanism coordinating the transcriptional response to low-
O2 environments (Semenza, 2011). In the intestine, HIF target
genes are basally regulated by normal physiology tomaintain tis-
sue barrier and include genes critical for microbial defense (Kelly
et al., 2013), xenobiotic clearance (Wartenberg et al., 2003), bar-
rier function (Furuta et al., 2001), mucin production (Louis et al.,
2006), and cellular energetics (Glover et al., 2013). Furthermore,
epithelial HIF has emerged a therapeutic target in colitis. In ani-
mal models, both genetic (Tambuwala et al., 2010; Karhausen
et al., 2004) and pharmacologic (Keely et al., 2014; Robinson
et al., 2008; Hindryckx et al., 2010) stabilization of HIF are dis-
ease protective, while loss of epithelial HIF-1a increases suscep-
tibility to colitis (Karhausen et al., 2004). Despite the central role
of HIF in maintenance of epithelial barrier function and the criticalnc.
role of O2 metabolism during inflammation (Campbell et al.,
2014), the determinants of such ‘‘physiologic hypoxia’’ have
not been characterized.
Butyrate has long been recognized as a favored metabolic
substrate for epithelial energy homeostasis (Donohoe et al.,
2011). Despite O2 scarcity, high concentrations of butyrate direct
metabolism away from glycolysis and toward further butyrate
utilization (Blouin et al., 2011). These observations lead us to hy-
pothesize that epithelial metabolism of SCFA are a primary
determinant of ‘‘physiologic hypoxia’’ in the mucosa. We show
that SCFA promote intestinal epithelial O2 consumption to the
extent that HIF is stabilized and the expression of barrier-protec-
tive HIF target genes, linking microbe, metabolism, and mucosal
innate immunity.
RESULTS
Analysis of PMDZDye Retention in HealthyMouseColon
Initially, we examined ‘‘physiologic hypoxia’’ using the O2-sensi-
tive dye pimonidazole (PMDZ), which is retained in tissues at pO2
levels % 10 mm Hg (Pogue et al., 2001). As shown in Figure 1
(additional images in Figure S1S), analysis of mouse colon sec-
tions (n = 12 mice) for retention of PMDZ along the crypt-villous
axis (Figure 1A) revealed a prominent lumen-to-serosa gradient
of dye retention. Dye retention diminished exponentially from
the most luminal aspect (R2 = 0.89, p < 0.01 by ANOVA, Fig-
ure 1B), implicating a luminally derived signal that drives epithe-
lial metabolism.
SCFAs Enhance O2 Consumption in Intestinal Epithelial
Cell Lines
Microbiota-derived butyrate is recognized as the preferred
metabolic substrate for colonic epithelial cells (Roediger,
1980). We determined whether this preference for butyrate ex-
tends to O2 metabolism. We subjected cultured Caco2 cells to
glucose (5.55 mM) in the presence and absence of sodium buty-
rate (NaB), acetate, or propionate and monitored rates of O2
consumption. These experiments utilized a recently described
real-time O2 monitoring system integrating a fluorescent O2
sensor spatially separated from the cell monolayer (Campbell
et al., 2014). NaB (blue lines in Figure 1C) produced a significant
and sustained increase in O2 consumption compared with con-
trol (black lines, p < 0.05). Likewise, sodium acetate (Figure 1D,
p < 0.05) and to a lesser extent sodium propionate (Figure 1E,
p > 0.05) treatments also increased O2 consumption. Such
changes in O2 consumption were abolished by co-treatment
with oligomycin, an inhibitor of mitochondrial respiration (red
lines). Likewise, the rate of O2 consumption at 30 min was
increased with NaB (4.6- ± 1.7-fold, p < 0.05) and acetate
treatment (2.9- ± 1.4-fold, p < 0.05) and was abolished by co-
treatment with oligomycin (Figures 1F–1H). Physiologic concen-
trations of NaB (10mM) provided the greatest reduction inmedia
O2 content (20.1% ± 5.7%, p < 0.01) compared to media alone
(Figure 1I). The rate of O2 consumption, calculated after
30 min, was also greatest with 10 mM NaB (p < 0.01), as shown
in Figure 2J. To validate this system (Campbell et al., 2014), we
employed the XF analyzer to quantify epithelial metabolic
responses to NaB. As shown in Figure 1K, treatment of Caco2
cell monolayers with NaB (10 mM) resulted in a profound in-Cell Hcrease in theO2 consumption rate over a 100min period of moni-
toring (p < 0.01).
To confirm that O2 depletion was dependent on respiration,
we generated Rho-0 mitochondrial–depleted Caco2 cells
(83% ± 10% loss of mDNA compared with control, p < 0.05; Fig-
ure 1L). Rho-0 Caco2 cells exhibited reduced O2 consumption
(4.7% ± 2.2% Rho-0 versus 15.4% ± 4.8% control) in
response to 10 mM NaB treatment (Figure 1M), confirming mito-
chondria-dependent O2 consumption. Such findings implicate
SCFAs in the enhancement of mitochondrial-dependent O2 con-
sumption by cultured epithelial cell lines.
NaB Stabilizes HIF
We next sought to determine whether changes in local O2 levels
by NaB were sufficient to stabilize HIF. Herein, Caco2 cells were
transfected with a canonical HIF reporter plasmid and assessed
for HIF stabilization. Acetate did not significantly increase lucif-
erase activity (Figure 2A). By contrast, 10mM sodium propionate
and NaB increased luciferase activity (9.8- ± 3.2-fold and 11.8- ±
3.2- fold, respectively; p < 0.01). The HIF-stabilizing prolyl hy-
droxylase domain (PHD) inhibitor DMOG was used as a positive
control and significantly increased HIF reporter activity (Fig-
ure 2A, p < 0.05). Consistent with our observations in O2 con-
sumption responses (see Figure 1), the addition of oligomycin
in combination with SCFAs significantly blunted this luciferase
reporter response (Figure 2A).
We next sought to quantify HIF-1a protein in response to NaB.
As depicted in Figure 2B, 8 hr of NaB (10 mM) significantly
increased nuclear HIF-1a (2.7- ± 0.26-fold, p < 0.05). By compar-
ison, thePHD inhibitorDMOG increasednuclearHIF-1aby15.3-±
5.3-fold (p < 0.05). In parallel, we visually assessed the influenceof
NaB on O2 tension within the cell monolayer using PMDZ. As
shown in Figure 2C, PMDZ retention provided visual confirmation
that NaB reduced local pO2 levels in cultured Caco2 cells.
We next determined whether NaB-induced stabilization of HIF
extended to the transcriptional regulation of target genes. Here,
we utilized real-time PCR to profile the influence of NaB on a
number of established HIF target genes. As shown in Figure 2D,
exposure of intestinal epithelia to a physiologic concentration
of NaB (10 mM) for 0 and 8 hr resulted in variable induction of
genes involved in adenosine metabolism/signaling (ADORA2B),
cell survival (BNIP3 and BNIP3L), and glycolytic metabolism
(PFKB3, LDH, and SLC2A1). For each of these HIF target genes,
NaBwas as potent, and in some casesmore so, than the positive
control DMOG.
As an additional line of evidence to interrogate NaB-induced
HIF responses, we quantified the induction of the HIF target
gene CKM (Glover et al., 2013) by NaB (10 mM, 8 hr) in lentiviral
shRNA-mediated knockdown of Hif1b relative to non-targeting
shRNA controls. As shown in Figure 2E, this analysis revealed
a prominent loss of CKM induction by NaB in cells lacking
HIF-1b. These findings indicate that SCFAs, particularly NaB,
influences epithelial O2 metabolism to the extent that HIF is
stabilized and transcriptionally active.
Broad-Spectrum Antibiotics diminish ‘‘Physiologic
Hypoxia’’
We next used broad-spectrum antibiotics (Abx) to deplete bac-
teria in vivo, with the goal of diminishing colonic SCFAs. 3 daysost & Microbe 17, 662–671, May 13, 2015 ª2015 Elsevier Inc. 663
(legend on next page)
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of Abx administered by oral gavage resulted in a nearly complete
loss of bacterial groups detected by 16S denaturing gradient gel
electrophoresis (Figure 3A). Despite outgrowth of several resis-
tant organisms (Figure 3A), cecal contents from Abx-treated
mice lost the ability to produce SCFAs from inulin (Figure 3B),
which was reflected by inability to change the color of pH-sensi-
tive (bromocresol purple) agar plates cultured in reduced-O2
conditions (Figure 3B; yellow indicates pH < 5.2). Stool cultures
of fecal pellets plated on brain-heart infusion medium revealed a
complete loss of culturable anaerobes following 3 days of oral
Abx treatment (Figure 3C, p < 0.025). In parallel, we measured
cecal SCFA concentrations. Abx treatment reduced cecal con-
tent of acetate, propionate, and NaB by 87% ± 2%, 91% ±
4%, and 92% ± 4%, respectively (Figure 3D, all p < 0.001).
To determine whether such conditions translated to a change
in epithelial metabolism in vivo, we localized the O2-sensitive
PMDZ dye in the colons of Abx-treated mice. This analysis
confirmed previous reports of basal ‘‘physiologic hypoxia’’ (Col-
gan and Taylor, 2010) in a luminal-to-serosal gradient across the
epithelium of control animals (Figure 3E and analysis from Fig-
ure 1). Abx treatment resulted in a striking reduction of probe
retention (Figure 3E), thereby indicating that microbial-derived
luminal signals determine basal tissue oxygenation.
To further quantify the influence of microbial signals to HIF sta-
bilization, we utilized a HIF reporter mouse (ODD-Luc) with
ubiquitous expression of firefly luciferase linked to the same
O2-dependent degradation domain contained in the HIF-1a sub-
unit (Safran et al., 2006). Abx treatment in these mice reduced
colon luciferase by 43.4% ± 7.4% (Figure 3F). Direct measure-
ment of HIF-1a protein revealed a 69.2% ± 5.3% reduction
compared with untreated animals (Figure 3G, p < 0.001).
Since broad-spectrum Abx can have independent influences
on a number of functional endpoints, we extended these findings
of PMDZ retention and basal epithelial HIF expression to germ-
free mice. As shown in Figure 3H (additional images included
as Figure S2S), a comparison of germ-free and conventionally
reared animals revealed that tissue pO2 (as reflected by PMDZ
retention) showed a nearly complete absence of the state of
‘‘physiologic hypoxia’’ (Figures 3H and 3I, p < 0.001) as well as
a significant decrease in the expression of epithelial HIF-1a
(Figure 3J, p < 0.001). These findings in germ-free mice confirm
our in vitro findings in vivo and strongly implicate luminal signals,
including SCFAs, as major determinants of ‘‘physiologic
hypoxia’’ in the healthy colon.Figure 1. Microbial-Derived Short-Chain Fatty Acids Promote Localize
(A) Mice (n = 12) were administered PMDZ 30 min prior to sacrifice. Colon samp
structions and counterstained with DAPI.
(B) For analysis of ‘‘physiologic hypoxia’’ along the length of the lumen-to-serosa
where 100 mm sections were divided into equivalent 10 mm and quantified for PMD
(C–E) Real-time O2 content in responses to 10 mMNaB (C), acetate (D), and propi
phosphorylation by the addition of oligomycin to each SCFA treatment increased
(F and G) The rate of O2 consumption 30 min after treatment with NaB (F) and ac
(H) Sodium propionate did not significantly influence the rate of O2 consumption
(I) O2 content of media was inversely related to concentration of NaB treatment w
(J) Rate of O2 consumption 30 min after treatment was also greatest with 10 mM
(K) Validation of the method for O2 consumption using the XF Analyzer. Shown he
Caco2 cell O2 consumption over a period of 100 min (p < 0.01).
(L and M) Mitochondria-depleted Caco2 cells (L) consumed less O2 compared w
([I]–[M]) or four ([A]–[H]) independent experiments. Significance was determined
Cell HDirect Actions of NaB on Epithelial O2 Metabolism and
Barrier Function
We next sought to define whether NaB influenced epithelial
metabolism and function. Initially, we determined whether the
addition of NaB could restore ‘‘physiologic hypoxia’’ in Abx-
treated mice (see Figure 3). Gross organ imaging in Abx-treated
ODD-Luc animals 4 hr after oral gavage of NaB (5 g/kg) (Egorin
et al., 1999) revealed intense HIF stabilization (reflected as tissue
luciferase) in the cecum (Figure 4A). Given that butyrate can be
absorbed in the proximal gut (Egorin et al., 1999), in subsequent
studies we gavaged tributyrin (1,2,3-tributyrylglycerol [TBN]) as
an analog of butyrate. TBN is a concentrated form of butyrate
that is sodium free and exhibits delayed absorption with greater
likelihood of increasing luminal butyrate in the distal gut. In Abx-
treated animals, oral gavage of TBN increased cecal butyrate
from undetectable levels to 19.2 ± 7.9 mM/g (p < 0.05; Figure 4B).
Interestingly, acetate also increased after bolus administration of
TBN by 1.98- ± 0.48-fold (p < 0.05; Figure 4B). Propionate was
undetectable in these samples. Using Abx-treated ODD-Luc
animals, we quantified luciferase activity in the cecum at 4, 8,
12, and 24 hr following TBN administration. As shown in Fig-
ure 4C, oral gavage of TBN elicited a 3.6- ± 1.1-fold and 4.5- ±
1.5-fold increase in cecal luciferase at 8 and 12 hr, respectively
(both p < 0.05). Similar results were obtained by probing for
HIF-1a protein directly using western blot (Figure 4D), which re-
vealed a 2.4- ± 0.04-fold increase in HIF-1a by 8 hr (Figure 4D).
Likewise, we found that oral administration of TBN subsequent
to Abx treatment increased epithelial retention of an O2-sensitive
probe pimodinazole in a patchy distribution (Figure 4E).
Finally, we sought to determine the contribution of HIF to
maintenance of barrier integrity in the context of butyrate. We
confirmed the barrier protective influences of NaB (10 mM for
24 hr.) on the rate of flux of 3-kD FITC-dextran through Caco2
monolayers, which was reduced by 30% ± 7% compared with
control (p < 0.05; Figure 4G). To specifically test the role of HIF
in NaB treatment, we generated lentiviral HIF-1b knockdown in
T84 cells. This achieved 69% knockdown compared to short
hairpin (Sh) control cells as evaluated bywestern blot (Figure 4F).
We then compared the flux ratio of NaB/control treatment using
3-kD FITC-dextran in these high-resistance HIF-1b knockdown
and Sh control monolayers. This revealed 6.3- ± 1.8-fold greater
NaB/control flux ratio in HIF-1b knockdown compared with Sh
control (p < 0.05), indicating a fundamental role for HIF in main-
taining barrier integrity (Figure 4G). These studies reveal thatd O2 Depletion
les were paraffin-embedded and stained according to the manufacturer’s in-
axis, samples (n = 3 per animal) were photographed and imported into ImageJ,
Z retention. Results are pooled and plotted as fluorescence intensity per mm2.
onate (E) (blue) were compared to vehicle control (black). Inhibition of oxidative
O2 content in media (red). Error bars represent SEM.
etate (G) was increased (p < 0.05).
.
ith the greatest decrease at the physiologic concentration of 10 mM (p < 0.01).
NaB (p < 0.01).
re is the influence of buffer (closed circles) and 10mM NaB (closed squares) on
ith control after exposure to NaB (M). Data represent mean ± SEM from three
using one-way ANOVA ([F]–[K]) and Student’s t test ([L] and [M]).
ost & Microbe 17, 662–671, May 13, 2015 ª2015 Elsevier Inc. 665
Figure 2. Buytrate Stabilizes HIF-1a and Transactivates HIF Target Genes
(A) The influence of acetate, propionate or NaB at indicated concentrations on the HIF HRE response (p < 0.01 for propionate and NaB). The response was
abolished with oligomycin co-treatment in Caco2 cells transfected with a HIF reporter plasmid. DMOG is shown as a positive control.
(B) NaB treatment for 8 hr increased nuclear HIF-1a in Caco2 cells (p < 0.05). This treatment increased retention of the O2-sensitive probe in Caco2 cells.
(C and D) Exposure of Caco2 cells to vehicle (gray bar), NaB (10 mM, 8 hr, black bars), or positive control DMOG (1 mM, 8 hr, white bars) induced indicated HIF
target gene expression (D).
(E) Influence of NaB on the expression of the HIF target gene CKM in T84 cells expressing lentiviral shRNA against Hif1b (Hif1b KD) relative to non-
targeting control lentivirus (Sh Ctl). Data represent average ± SEM of three independent experiments. Significance determined using one-way ANOVA.
*p < 0.05; **p < 0.01.microbial-derived SCFAs play a central role in O2 metabolism in
the colon in vivo and implicate a protective influence of butyrate
on HIF-regulated barrier function.
DISCUSSION
There is currently significant interest in understanding how the
host communicates with the microbial world (Lozupone et al.,
2012). Epithelial cells are uniquely positioned to function as the
primary interface for host-microbial communication. We report
here that epithelial metabolism of SCFAsmay serve as an impor-
tant yet underappreciated conduit for communication between
the host and luminal microbes.666 Cell Host & Microbe 17, 662–671, May 13, 2015 ª2015 Elsevier IGiven the range of available substrates, it is notable that a pre-
dominant energy source is butyrate, an end product of bacterial
metabolism. Butyrate typically constitutes 15%–20% of SCFA in
the human colon with absolute concentrations above 10 mM
in human feces (Hamer et al., 2008). Butyrate is efficiently
absorbed and metabolized by the epithelium, and in contrast
to other SCFAs, little butyrate is released into portal circulation
(Hamer et al., 2008). One factor contributing to the preference
of the colonic epithelium for butyrate is that butyrate stimulates
expression of pyruvate dehydrogenase kinases, which inhibit
the pyruvate dehydrogenase complex (Blouin et al., 2011). In
this report, we demonstrate that metabolism of butyrate, and
to a lesser extent acetate and propionate, by epithelial cell linesnc.
Figure 3. Antibiotics Reduce SCFA Concentration and HIF in the Colon
(A) Denaturing gradient gel electrophoresis, where each lane represents an individual animal and each band represents a distinct bacterial population, revealed
depletion of most bacterial populations in the cecum of ODD-Luc mice with Abx treatment.
(A and B) Despite appearance of resistant organisms (A), cecal contents from Abx-treated mice lost their ability to ferment inulin to SCFA. Each plate contained
cecal contents from an individual animal, and yellow color indicates pH < 5.2 (B).
(C) Analysis of culturable stool microbiota from vehicle and Abx-treated mice (n = 7 per group, where ** indicates p < 0.025).
(D) Accordingly, cecal acetate, propionate, and NaB were reduced with Abx treatment (p < 0.001).
(A–C) Data represent average ± SEM from three independent experiments ([A] and [B]). Each lane (A), dish (B), and symbol (C) represent an individual
animal.
(E) Significance was determined using Student’s t test. Abx treatment reduced retention of PMDZ in the colon indicating loss of ‘‘physiologic hypoxia.’’
(F and G) This influence reflected reduced luciferase activity ([F], p < 0.001) and HIF-1a protein ([G], p < 0.001) in the colon of ODD-Luc animals.
(H) PMDZ localization in control and germ-free mouse colon (n = 6 per group). PMDZ was quantified (H) where *** indicates p < 0.001.
(J) HIF-1a protein in control and germ-free mouse colon (n = 6 per group). Data represent average ± SEM from three independent experiments where *** indicates
p < 0.001.
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Figure 4. Butyrate Rescues ‘‘Physiologic Hypoxia’’ and Protects Barrier via HIF
(A) 4 hr following oral gavage of butyrate, tissue luciferase activity increased in the distal gut of Abx-treated ODD-Luc mice.
(B–D) Oral gavage of TBN increased cecal acetate and butyrate (B), luciferase activity (C), and HIF-1a protein (D) in Abx-treated ODD-Luc mice.
(E) Daily TBN gavage for 3 days increased retention of O2-sensitive probe in the colon of Abx-treated mice (n = 6 per group).
(F) Validation of lentiviral knockdown of HIF-1b in high-resistance T84 monolayers is shown by western blot.
(G) Role of HIF-1b in mediating influences of NaB treatment is shown by the lower flux ratio in NaB/control-treated control cells comparedwith HIF-1 b knockdown
cells (p < 0.05). Data represent average ± SEM from three independent experiments.
(C, F, and G) Significance was determined using Kruskal-Wallis (C) and Student’s t test ([F] and [G]).depletes local O2 to the extent that HIF is stabilized. Given the
multiple levels of protection provided by basal HIF expression
within the mucosa (Colgan and Taylor, 2010), these findings
reveal a host-microbe crosstalk pathway wherein SCFAs may
signal protective distal gut functions.
Accumulated literature supports butyrate as anti-carcino-
genic, anti-inflammatory, and barrier protective in the distal gut
(Plo¨ger et al., 2012; Hamer et al., 2008). The protection afforded
by fiber and resistant starch in experimental colitis are thought to
be dependent on SCFA production (Ito et al., 2009; Morita et al.,
2004; Videla et al., 2001), and administration of exogenous buty-
rate promotes resistance to experimental colitis (Cresci et al.,
2013; Leonel et al., 2013). Studies investigating dysbiosis in in-668 Cell Host & Microbe 17, 662–671, May 13, 2015 ª2015 Elsevier Iflammatory bowel disease identified reduced abundance of
butyrate-producing organisms (e.g., certain Roseburia and Fae-
calibacterium genera) and lower concentrations of butyrate
associated with disease (Machiels et al., 2013; Eeckhaut et al.,
2013; Sokol et al., 2009). The importance of butyrate as the
preferred epithelial substrate has been highlighted by demon-
stration that pharmacologic inhibition of b-oxidation induces
colitis (Roediger and Nance, 1986) and that mice with mitochon-
drial polymorphisms that maintain increased oxidative phos-
phorylation activity are resistant to colitis (Bar et al., 2013).
Several trials have evaluated the efficacy of butyrate in the treat-
ment of human disease, primarily ulcerative colitis, with mixed
results (Hamer et al., 2008). This variability might be explainednc.
by impaired uptake and metabolism of butyrate associated with
inflammation, implying that maintenance of remission may be a
more rational therapeutic goal (De Preter et al., 2012). The phys-
iologic role of SCFAs in mucosal protection is perhaps best illus-
trated in colitis caused by surgical diversion of the fecal stream,
where restoration of luminal SCFAs is a first-line therapy (Harig
et al., 1989).
The pleiotropic influences of butyrate in the mucosa make it
difficult to isolate influences of the HIF pathway from previously
established mechanisms of action, including HDAC inhibition,
stimulationofGPR43andGPR109a, andmetabolic fuel. It is likely
that the mechanisms involved are synergistic with HIF stabiliza-
tion. For example, we show that butyrate, a classic HDAC inhibi-
tor, increases HIF in epithelial cell lines. This could enable HIF to
alter transcription of genes that would otherwise be inaccessible
by chromatin structure. A caveat to our studies here is recent
work that demonstrated that the primary energy source for
cancerous colonocytes is glucose (i.e., the Warburg effect) and
that, in high concentrations of butyrate, functions primarily as
an HDAC inhibitor (Donohoe et al., 2012). It remains unclear to
what extent butyrate might influence glucose utilization by
colonic cell lines. A recent report indicated that activated AMPK
is an endogenous inhibitor of the Warburg effect (Faubert et al.,
2013), and that butyrate is a potent activator of AMPK in colonic
cell lines (Elamin et al., 2013). Donohoe et al. (2011) showed
that compared with conventionalized mice, the colonocytes of
germ-free mice are ATP deficient and the provision of butyrate
can reverse this energy deficit by restoring oxidative respiration.
Likewise, we report here that germ-free animals lack the classical
‘‘physiologic hypoxia.’’ This observation is unlikely to be an arti-
fact of PMDZ biochemistry in germ-free animals, since a strong
correlation exists between hypoxia and PMDZ binding (Arteel
et al., 1995). One caveat is the presence of nitroreductases in
some inflammatory cells that can reduce PMDZs in an O2-insen-
sitive manner (Kizaka-Kondoh and Konse-Nagasawa, 2009). Our
analysis also indicated that germ-free animals express less
epithelial HIF-1a. Given the intrinsic link between oxidative phos-
phorylation andATPgenerationwithO2 consumption, it is difficult
to separate ATP generation from O2 consumption and, in this re-
gard, HIF pathway activation.
For a number of reasons, it is likely that HIF stabilization by
butyrate augments epithelial barrier in the healthy colon and in
underlying disease. First, epithelial HIF stabilization is linked at
many levels to enhanced epithelial barrier in vitro and in vivo
(Glover and Colgan, 2011). Recent studies have, for example,
identified important roles for localized O2 metabolism (Campbell
et al., 2014) and alternative energy sources (e.g., creatine; Glover
et al., 2013) as important components to intestinal homeostasis.
Second, the enhanced barrier function we report in butyrate-
treated HIF-1b knockdown cells demonstrates a role for HIF, in-
dependent of ATP generation. In this context, we demonstrate
that CKM is a differentiating target in response to butyrate in
the Hif1b KD cell line. CK’s were recently shown to function as
a fundamental link between cellular energy and junctional integ-
rity in colonic epithelial cells (Glover et al., 2013). This observa-
tion is supported by a growing literature that has established
the role of HIF-1a in mucosal protection in vivo (Hindryckx
et al., 2010; Karhausen et al., 2004; Keely et al., 2014, Robinson
et al., 2008; Tambuwala et al., 2010).Cell HThis work highlights the importance of HIF stabilization
through SCFA metabolism as an independent mechanism to
promote homeostasis in the distal intestine. This host-microbial
crosstalk axis provides important insight into how microbial-
derived products ultimately influence tissue function.
EXPERIMENTAL PROCEDURES
Additional details can be found in Supplemental Information
Analysis of PMDZ Dye Retention in Colon
PMDZ (Hypoxyprobe, Inc.) was administered by intraperitoneal injection
30 min prior to sacrifice and samples were analyzed as before (Campbell
et al., 2014). For analysis of ‘‘physiologic hypoxia’’ along the length of the
lumen-to-serosa axis, samples were photographed and imported into ImageJ,
where 100 mm sections were divided into equivalent 10 mm and quantified for
PMDZ retention.
Cell Culture, shRNA Knockdown, and Mitochondrial Depletion
Caco2 and T84 cells were cultured as described previously (Glover et al.,
2013). The generation of Hif1b KD cell lines using lentiviral particles encoding
shRNA were performed as described before (Glover et al., 2013). Mitochon-
drial depletion was accomplished by passaging Caco2 cells in 50 ng/ml
ethidium bromide for a minimum of 2 weeks (King and Attardi, 1996).
Real-Time O2 Consumption
The SensorDish Reader from Applikon Biotechnology was used as described
previously (Campbell et al., 2014).
Protein Analysis and Immunofluorescence
HIF-1a protein was quantified after nuclear and cytoplasmic extraction as
described previously (Glover et al., 2013).
Gene Expression
Real-time PCR analysis was performed as described elsewhere (Glover et al.,
2013) using primer sets described in Supplemental Information.
FITC-Dextran Flux
Flux of 3kD FITC-dextran was utilized to quantify barrier function as described
previously (Sanders et al., 1995).
Animal Studies
Studies in HIF-luciferase reporter mice (Safran et al., 2006) were performed as
described elsewhere (Campbell et al., 2014) and detailed in Supplemental
Information. SCFA quantification was performed with gas chromatography-
mass spectrometry (GC-MS) following extraction of SCFAs from cecal con-
tents in acidified water as described elsewhere (Weir et al., 2013). Additional
details in Supplemental Information.
Germ-Free Mice
Mice were bred and maintained in flexible vinyl positive pressure isolators
within the Gnotobiotic Facility at the University of Colorado as described in
Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chom.2015.03.005.
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